Mineralys Therapeutics MLYS
$13.66 −$0.50 (-3.53%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.70 +0.29%
Open$13.81
Prev close$14.16
Day range$13.57 – $14.79
Volume1.35M
Market cap$1.21B
P/E (TTM)–
Dividend yield–
MLYS Stock News
Headlines matching Mineralys Therapeutics or the MLYS ticker, most recent first.
- Mineralys Therapeutics(MLYS.US) Director Sells US$3.01 Million in Common Stock
- Form 144 | Mineralys Therapeutics(MLYS.US) Director Proposes to Sell 3.01 Million in Common Stocks
- Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)
- A Quick Look at Today's Ratings for Mineralys Therapeutics(MLYS.US), With a Forecast Between $40 to $56
- Bank of America Securities Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)
- LifeSci Capital Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $54
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), Legend Biotech (LEGN) and Mineralys Therapeutics, Inc. (MLYS)
- H.C. Wainwright Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $56
- Mineralys Therapeutics, Inc. (MLYS) Gets a Buy From Wells Fargo
- Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (MLYS) and ArriVent BioPharma, Inc. (AVBP)
- Goldman Sachs Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $42
- A Quick Look at Today's Ratings for Mineralys Therapeutics(MLYS.US), With a Forecast Between $42 to $56
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Myriad Genetics (MYGN) and Mineralys Therapeutics, Inc. (MLYS)
- Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Context Therapeutics (CNTX) Positive
- TD Cowen Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating
No comments yet — be the first to weigh in on MLYS.
Sign in to join the discussion.